squamous cell carcinoma of the head and neck (scchn)
Showing 1 - 10 of 10
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Worldwide (palbociclib, Cetuximab, Placebo)
Completed
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- palbociclib
- +2 more
-
La Jolla, California
- +70 more
Oct 10, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022
Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab Vedotin (HuMax-TF-ADC))
Completed
- Ovary Cancer
- +7 more
- Tisotumab Vedotin (HuMax-TF-ADC)
-
Orange, California
- +28 more
Nov 29, 2021
Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- avelumab
- +3 more
-
Rochester, New York
- +4 more
Sep 17, 2021
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and
Completed
- Cervical Cancer
- +16 more
- INCAGN02385
-
Los Angeles, California
- +3 more
Oct 28, 2020
Squamous Cell Carcinoma of the Head and Neck (SCCHN), Ovarian Carcinoma-Enrollment Completed, Colorectal Cancer (CRC)-Enrollment
Completed
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- +4 more
- Combination of varlilumab and nivolumab
-
Tucson, Arizona
- +18 more
Dec 5, 2019
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Bevacizumab
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 15, 2017
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Ann Arbor, Detroit (AT-101, Docetaxel)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
-
Ann Arbor, Michigan
- +1 more
Mar 3, 2016